首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
【24h】

Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.

机译:二羟基化2,4,6-三苯基吡啶:合成,拓扑异构酶I和II抑制活性,细胞毒性和结构 - 活性关系研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Twelve dihydroxylated 2,4,6-triphenyl pyridines were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of 2- and 6-phenyl, or 2- and 4-phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Generally, dihydroxylated 2,4,6-triphenyl pyridines exhibited stronger topoisomerase II inhibitory activity, and cytotoxicity compared to those of monohydroxylated 2,4,6-triphenyl pyridines. The concrete structure-activity relationship was observed that dihydroxylated 2,4,6-triphenyl pyridines with hydroxyl group at meta or para position of 2-phenyl ring displayed significant topoisomerase II inhibitory activity as well as cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for compounds 10, 12, 13, 17-20 and 22.
机译:设计并合成了12种二羟基化的2,4,6-三苯基吡啶,其在邻摩尔,2-苯基的2-和6-苯基的位置,或附着在中央吡啶上的2-和4-苯基环处的羟基。 它们评估了拓扑异构酶I和II抑制活性,以及针对几种人类癌细胞系的细胞毒性用于开发新的抗癌剂。 通常,与单羟基化的2,4,6-三苯基吡啶相比,二羟基化的2,4,6-三苯基吡啶表现出较强的拓扑异构酶II抑制活性,细胞毒性。 观察到混凝土结构 - 活性关系与2-苯环的羟基的二羟基化2,4,6-三苯基吡啶显示出2-苯基环的羟基,显示出显着的拓扑异构酶II抑制活性以及细胞毒性。 对于化合物10,12,13,17-20和22,观察到拓扑异构酶II抑制活性和细胞毒性之间的正相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号